SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Warner Bros. Discovery, Inc. is a premier global media and entertainment company, which engages in the provision of a differentiated portfolio of content, brands, and franchises across television, film, streaming, and gaming. It operates through the following segments: Studios, Networks, Direct-to-Consumer (DTC), and Corporate. The Studios segment includes producing and releasing feature films for initial exhibition in theaters, producing and initial licensing television programs to networks services as well as third parties, distributing films and television programs to various third party, internal television, and streaming services, distribution through the home entertainment market related consumer products, and themed experience licensing and interactive gaming. The Networks segment focuses on domestic and international television networks. The DTC segment is involved in premium pay-television and streaming services. The company was founded on June 17, 1985 and is headquartered in New York, NY.

Warner Bros. Discovery Inc - Ordinary Shares - Class A

Warner Bros Discovery Inc

Warner Bros. Discovery is trending amid speculation about a potential acquisition, with the community closely watching for a deal announcement, especially with earnings on the horizon.  Executive share selling and potential offers are hot topics.  The stock's valuation and possible bidding war dynamics are also being heavily debated by investors.

Internet Computer (IC) is the world’s first blockchain that is capable of running at web speed at unrestrictive capacities. Built by the DFINITY Foundation, IC aims to recreate the web by supporting smart contract development at scale and changing the way people can interact using web services. Internet Computer aims to extend the public internet, so that it can be the world’s computing platform, in a decentralized manner. Internet Computer sets to revolutionalize the design of the crypto economy, with an aim to overhaul traditional software services.   The project was founded in October 2016 by Dominic WIllams and have raised a total of $121 million from investors such as Adreessen Horowitz, Polychain Capital, Multicoin Capital and such. On May 10, 2021, DFINITY launched the Internet Computer into the public domain, marking it a major milestone for ICP as it means the internet now functions as a decentralised global computer. This is marked by the release of all of the Internet Computer’s source code into the public domain, as well as ICP utility token that allows tens of thousands of community members to govern the Internet Computer network.  ICP is Internet Computer's native token. It plays three prominent roles:  1. Network Governance: Users that participate in the governance will be rewarded with ICPI 2. Production of Cycles for Compute: ICP can be converted into cycles where it is used as the transaction fee to access the network. Cycles are burned after used. 3. Rewarding Users: ICP is used as the rewards to incentivize users to participate in the network such as securing the network.

Internet Computer

Internet Computer ($ICP) is trending as the community rallies around its potential to challenge Big Tech with its decentralized, open infrastructure, with some speculating about game-changing news.  Discussions highlight the token's recent price momentum and potential resistance levels, while others point to its advanced decentralized cloud ecosystem. Community members are actively watching for a breakout and anticipating a run, while noting the high trading volume.

Celsius Holdings, Inc. engages in the development, marketing, sale, and distribution of functional drinks and liquid supplements. It also offers post-workout functional energy drinks and protein bars. The company was founded in April 2004 and is headquartered in Boca Raton, FL.

Celsius Holdings Inc

CELH is trending as investors anticipate upcoming earnings results, with many in the community expecting strong numbers driven by growth and the Alani Nu acquisition. Despite overall market uncertainty, the community expresses long-term confidence in CELH's execution and potential, while also closely monitoring potential short-term volatility and market manipulation.

Snap, Inc. operates as a technology company, which engages in the provision of a visual messaging application that was created to help people communicate through short videos and images. The company was founded by Frank Reginald Brown IV, Evan Thomas Spiegel, and Robert C. Murphy in 2010 and is headquartered in Santa Monica, CA.

Snap Inc - Ordinary Shares - Class A

Snap Inc

Snap's stock is surging as investors react to a Q3 earnings beat, a $500 million stock buyback, and a new $400 million AI partnership with Perplexity. The community is buzzing about the potential for a short squeeze and upgraded price targets, while also weighing concerns about profitability and the long-term sustainability of the rally.

Direxion Shares ETF Trust - Direxion Daily Semiconductor Bull 3X Shares

Direxion Daily Semiconductor Bull 3X Shares

SOXL is trending as traders assess the semiconductor sector's near-term trajectory amidst AI optimism and US-China trade concerns. Community discussions include reactions to earnings reports from key semiconductor companies and speculation about upcoming economic data releases and Federal Reserve actions. Bullish sentiment persists, while some are wary of overvaluation and the potential for a pullback.

Duolingo, Inc. is a language-learning website and mobile application, which engages in the development of a free language learning website and crowd sourced text translation platform. It offers Duolingo for Schools, a free, web-based tool that aims to make it easier for teachers to use the Duolingo platform in a structured learning environment, and English Test, an online, on-demand assessment of English proficiency. The company was founded by Luis von Ahn and Severin Hacker in 2011 and is headquartered in Pittsburgh, PA.

Duolingo Inc - Ordinary Shares - Class A

Duolingo Inc

Duolingo is trending amid discussions about its post-earnings drop, despite reporting strong revenue and user growth, as the market reacts to future guidance and broader concerns about growth pace and AI competition. The community is debating whether the dip is an overreaction and a buying opportunity or a sign of deeper issues with the company's valuation and long-term prospects. Some traders are anticipating a potential bounce, while others believe the stock could fall further.

Didi Global, Inc. engages in the operation of mobility platforms that provides ride hailing and other related services. It operates through the following segments: China Mobility, International, and Other Initiative. The China Mobility segment consists of ride hailing, taxi hailing, chauffeur and hitch services. The International segment includes ride hailing and food delivery services in international markets, outside of China. The Other Initiatives segment mainly consists of bike and e-bike sharing, certain auto solutions, intra-city freight, community group buying, autonomous driving, and financial services. The company was founded by Wei Cheng, Qing Liu, Bo Zhang and Rui Wu on January 11, 2013 and is headquartered Beijing, China.

DiDi Global Inc - ADR

DiDi Global is trending due to a Daiwa Securities research note highlighting potentially larger-than-expected international losses driven by investments in its Brazilian food delivery expansion, causing investors to react to the hit in profitability. The community is discussing the impact of this downgrade amidst ongoing discussions of a potential HKEX relisting and settlement of legal issues. Some investors remain optimistic about the long-term potential of DiDi, particularly regarding its autonomous driving initiatives, while others express concern over market manipulation and short selling.

Caledonia Mining Corp. Plc engages in the exploration, development, and production of gold and other precious metals from its mineral properties. Its projects include Blanket Gold Mine and Maligreen. The company was founded on February 5, 1992 and is headquartered in St. Helier, the United Kingdom.

Caledonia Mining Corporation Plc

Caledonia Mining Corporation ($CMCL) is trending due to upcoming earnings and discussions around its potential growth, particularly the Bilboes project which could significantly increase production; the earnings are scheduled to be released Monday before the market opens. Community members are weighing the company's profitability against the political risks of operating in Zimbabwe, with some anticipating a positive impact from rising gold prices and others concerned about potential dilution from financing activities. Recent discussions also touch on the stock's valuation relative to its growth potential and comparison to other gold miners.

Alphabet, Inc. is a holding company, which engages in software, health care, transportation, and other technologies. It operates through the following segments: Google Services, Google Cloud, and Other Bets. The Google Services segment includes products and services, such as ads, Android, Chrome, devices, Google Maps, Google Play, Search, and YouTube. The Google Cloud segment refers to infrastructure and platform services, collaboration tools, and other services for enterprise customers. The Other Bets segment relates to the sale of healthcare-related services and internet services. The company was founded by Lawrence E. Page and Sergey Mikhaylovich Brin on October 2, 2015 and is headquartered in Mountain View, CA.

Alphabet Inc - Ordinary Shares - Class A

Alphabet Inc Class A

Alphabet (GOOGL) is trending following a strong earnings report, highlighting growth in cloud services and AI initiatives like Gemini, with analysts raising price targets. The community is discussing the stock's potential to reach new highs and its increasing valuation, while also debating its performance relative to other tech giants and the broader market. Some traders are noting potential pullbacks or consolidation phases, while others anticipate further upside driven by AI developments and strategic partnerships.

Rezolute, Inc. operates as a biopharmaceutical company, which engages in the development of drug therapies for patients with metabolic and orphan diseases. The firm's antibody therapy, ersodetug, is designed to treat all forms of hyperinsulinism. The company was founded by Nevan Charles Elam, Ho Young Huh, and Sankaram Mantripragada in March 2010 and is headquartered in Redwood City, CA.

Rezolute Inc

RZLT is trending due to positive updates on its lead drug candidate, Ersodetug, for congenital hyperinsulinism (CHI), including promising Phase 3 trial progress and Breakthrough Therapy Designation. Community discussion highlights potential M&A activity, positive analyst ratings, and robust options trading, all suggesting growing bullish sentiment. Speculation around accelerated management agreements and potential acquirers like Ultragenyx is adding to the buzz.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Ultragenyx (RARE) Reports Q3 Loss, Misses Revenue Estimates

Ultragenyx (RARE) delivered earnings and revenue surprises of -47.15% and -4.55%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

Apellis Pharmaceuticals, Inc. (APLS) Q3 Earnings and Revenues Top Estimates

Apellis Pharmaceuticals (APLS) delivered earnings and revenue surprises of +62.14% and +25.22%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fortress Biotech Inc. - FBIO

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fortress Biotech Inc. - FBIO INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fortress...

Fortress Biotech, Inc. (FBIO) shares slumped 30% in the pre-market session on Wednesday after the company announced that the U.S. Food and Drug Administration refused to approve CUTX-101 for the treatment of Menkes disease in pediatric patients.The FDA, in its letter, flagged concerns about the facility where CUTX-101 is manufactured. The letter did not cite any other approvability concerns or any deficiencies pertaining to CUTX-101’s efficacy and safety data, the company <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.globenewswire.com/news-release/2025/10/01/3159486/28889/en/Fortress-Biotech-and-Cyprium-Therapeutics-Announce-an-Update-on-the-NDA-for-CUTX-101.html">said</a>.U.S.-based biopharmaceutical company Sentyl Therapeutics is responsible for the development and commercialization of CUTX-101. It took over the responsibility from Fortress’s majority-owner unit, Cyprium Therapeutics, in December 2023.Fortress said on Wednesday that Cyprium expects Sentynl to work expeditiously to address the FDA’s concerns and pursue resubmission promptly.On Stocktwits, retail sentiment around <a href="https://stocktwits.com/symbol/FBIO">FBIO stock</a> rose from ‘bullish’ to ‘extremely bullish’ over the past 24 hours, while message volume improved from ‘high’ to ‘extremely high’ levels.The facility in question recently responded to the FDA’s September 2025 re-inspection, and Sentynl expects to request a meeting with the agency to discuss resubmission of the drug application, according to Fortress.Under the deal between Cyprium and Sentynl, Cyprium will be eligible to receive royalties on net sales of CUTX-101, if approved in the treatment of Menkes disease, and up to $129 million in aggregate development and sales milestones from Sentynl. Menkes disease is a rare, severe genetic disorder primarily affecting males, which impairs the body's ability to absorb and distribute copper, resulting in copper deficiency in the brain and other organs.FBIO stock is up 82% this year and approximately 158% over the past 12 months.&nbsp;Read also:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/carvana-stock-rallies-pre-market-after-jefferies-upgrade-price-target-hike/chCY5oIR3aK">Carvana Stock Rallies Pre-Market After Jefferies’s Upgrade, Price Target Hike</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Stock market down on a black background. | Image source: Yuichiro Chino via Getty Images

Why Is Fortress Biotech Stock Falling Today?

The FDA, in a letter, flagged concerns about the facility where CUTX-101 is manufactured.

Equity

The FDA, in a letter, flagged concerns about the facility where CUTX-101 is manufactured.



Fortress Biotech (FBIO) Reports Q2 Loss, Beats Revenue Estimates

Fortress Biotech (FBIO) delivered earnings and revenue surprises of -48.39% and +13.66%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Repare Therapeutics Inc. (RPTX) Reports Q2 Loss, Misses Revenue Estimates

Repare Therapeutics (RPTX) delivered earnings and revenue surprises of +30.36% and -95.00%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Coherus Oncology (CHRS) Reports Q2 Loss, Beats Revenue Estimates

Coherus Oncology (CHRS) delivered earnings and revenue surprises of -9.68% and +1.32%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Why Fast-paced Mover Fortress Biotech (FBIO) Is a Great Choice for Value Investors

If you are looking for stocks that have gained strong momentum recently but are still trading at reasonable prices, Fortress Biotech (FBIO) could be a great choice. It is one of the several stocks that passed through our 'Fast-Paced Momentum at a Bargain' screen.

Fortress Biotech, Inc. engages in the manufacture and commercialization of novel pharmaceutical products and product candidates. It operates through the Dermatology Product Sales and Pharmaceutical and Biotechnology Product Development segments. Its products include Ximino, Targadox, Exelderm, Ceracade, and Luxamend. The company was founded in 2006 and is headquartered in Bay Harbor Islands, FL.

Current Price	$2.48
Prev Close	$2.47
Open	$2.45
Dividend Yield	0.00%
50-Day Moving Average	$3.05
Beta	0.93
Avg. Volume	959,507.35
PE Ratio	-2.17

52-Week High	$4.20
52-Week Low	$1.33
Market Capitalization	$73.79M
EPS (Annual)	-$2.69
Price to Book	1.68
Revenue Per Employee	$571,039.60
Enterprise Value/EBITDA	N/A

FBIO
Fortress Biotech Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest FBIO News

FBIOFortress Biotech Inc